Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment
Legacy Convertible Preferred Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjusted Balance
Legacy Convertible Preferred Stock
Common Stock
Restricted Stock awards
Common Stock
Restricted Stock Units
Common Stock
Additional Paid-In Capital
Restricted Stock awards
Additional Paid-In Capital
Restricted Stock Units
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Restricted Stock awards
Restricted Stock Units
Total
BALANCE at Dec. 31, 2019 $ (436,553)                 $ 436,553                      
BALANCE (in shares) at Dec. 31, 2019 (100,038,109)                 100,038,109                      
BALANCE at Dec. 31, 2019   $ 13 $ 436,520 $ 436,533 $ 16 $ 453,242 $ (294,262) $ 75 $ 159,071       $ 3     $ 16,722 $ (294,262) $ 75     $ (277,462)
BALANCE (in shares) at Dec. 31, 2019   128,100,821     154,913,934               26,813,113                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Exercise of Common Stock options                               325         325
Exercise of Common Stock options (in shares)                         521,925                
Vesting of restricted Common Stock                         $ 1     6         7
Vesting of restricted Common Stock (in shares)                         5,307,357                
Repurchase of shares for employee tax withholdings                               (101)         (101)
Repurchase of shares for employee tax withholdings (in shares)                         (9,308)                
Issuance of Common Stock in connection with acquisitions                               500         500
Issuance of Common Stock in connection with acquisitions (in shares)                         61,060                
Stock-based compensation expense                               8,006         8,006
Common Stock warrants issued and exercised                               1,915         1,915
Common Stock warrants issued and exercised (in shares)                         692,366                
Reverse recapitalization, net of transaction costs                         $ 6     380,295         380,301
Reverse recapitalization, net of transaction costs (in shares)                         63,139,263                
Net loss                                 (34,015)       (34,015)
Other comprehensive income (loss)                                   (84)     (84)
BALANCE at Dec. 31, 2020                         $ 23     844,188 (328,277) (9)     515,925
BALANCE (in shares) at Dec. 31, 2020                         224,626,597                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Exercise of Common Stock options                         $ 1     6,425         6,426
Exercise of Common Stock options (in shares)                         5,732,247                
Vesting of restricted Common Stock (in shares)                         491,293                
Repurchase of shares for employee tax withholdings                           $ (958) $ (541)       $ (958) $ (541)  
Repurchase of shares for employee tax withholdings (in shares)                     (109,150) (61,498)                  
Vesting of restricted share units (in shares)                         650,777                
Issuance of Common Stock in connection with acquisitions                         $ 5     620,585         620,590
Issuance of Common Stock in connection with acquisitions (in shares)                         57,267,401                
Issuance of Common Stock in connection with acquired in-process research and development                               4,300         4,300
Issuance of Common Stock in connection with acquired in-process research and development (in shares)                         334,370                
Stock-based compensation expense                               28,778         28,778
Vesting of Trine Founder shares (in shares)                         1,850,938                
Common Stock issued in connection with warrants exercised                         $ 2     320,567         320,569
Common stock issued in connection with warrants exercised (in shares)                         20,690,975                
Net loss                                 (240,334)       (240,334)
Other comprehensive income (loss)                                   (6,405)     (6,405)
BALANCE at Dec. 31, 2021                         $ 31     1,823,344 (568,611) (6,414)     $ 1,248,350
BALANCE (in shares) at Dec. 31, 2021                         311,473,950                
BALANCE (in shares) at Dec. 31, 2022                                         100,038,109
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Exercise of Common Stock options                               3,190         $ 3,190
Exercise of Common Stock options (in shares)                         2,310,931                
Vesting of restricted Common Stock (in shares)                         157,131                
Repurchase of shares for employee tax withholdings                             $ (243)         $ (243)  
Repurchase of shares for employee tax withholdings (in shares)                       (74,719)                  
Vesting of restricted share units                         $ 1               1
Vesting of restricted share units (in shares)                         4,153,939                
Stock-based compensation expense                               48,001         48,001
Issuance of Common Stock related to settlement of contingent consideration                               500         500
Issuance of Common Stock related to settlement of contingent consideration (in shares)                         112,202                
Net loss                                 (740,343)       (740,343)
Other comprehensive income (loss)                                   (31,954)     (31,954)
BALANCE at Dec. 31, 2022                         $ 32     $ 1,874,792 $ (1,308,954) $ (38,368)     $ 527,502
BALANCE (in shares) at Dec. 31, 2022                         318,133,434